Skip to main content
Erschienen in: Supportive Care in Cancer 5/2005

01.05.2005 | Original Article

Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit

verfasst von: Radoslaw Owczuk, Magdalena A. Wujtewicz, Wioletta Sawicka, Anna Wadrzyk, Maria Wujtewicz

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Background

Mortality of patients with haematological malignancies requiring intensive therapy is high. We wanted to establish reasons for intensive care unit (ICU) admission and treatment as well as outcome in subjects who required invasive mechanical ventilation. We were also interested in differences between ICU survivors and non-survivors at the moment of admission.

Patients and methods

Forty patients (21 women and 19 men) were included in the study. Median of age was 42 (range 16–73) years. All patients required mechanical ventilation. We analysed age, gender, disease character (acute/chronic), diagnosed pneumonia, multiple organ failure (MOF), history of bone marrow transplantation, peripheral blood parameters (leukocyte, neutrocyte, erythrocyte and thrombocyte counts, haemoglobin level and haematocrit), mean arterial pressure (obtained through direct measurement), necessity of catecholamine administration and symptoms of the acute renal insufficiency at the moment of ICU admission.

Main results

Sixty-five percent of patients died in ICU. Intergroup comparisons between survivors and non-survivors revealed statistically significant differences in the presence of neutropenia, thrombocyte count, mean arterial pressure and the necessity of catecholamines administration, as well as scores obtained through patient evaluation according to the Acute Physiology and Chronic Health Evaluation (APACHE II), the Sequential Organ Failure Assessment (SOFA) and the New Simplified Acute Physiology Score (SAPS II) scales. Multivariate logistic regression revealed only one independent risk factor for ICU mortality in the analysed group—SAPS II score (p=0.009). Calculated value of the unitary odds ratio was 1.065 (95% confidence interval 1.017–1.116).

Conclusions

Mortality of patients with haematological malignancies requiring intensive mechanical ventilation remains high. Scoring with the SAPS II system was a useful tool for determination of ICU mortality risk in those patients.
Literatur
1.
Zurück zum Zitat Ashkenazi YJ, Kramer BS, Harman E (1986) Short-term outcome among patients with leukemia and lymphoma admitted to a medical intensive care unit. South Med J 79:1086–1088PubMed Ashkenazi YJ, Kramer BS, Harman E (1986) Short-term outcome among patients with leukemia and lymphoma admitted to a medical intensive care unit. South Med J 79:1086–1088PubMed
2.
Zurück zum Zitat Azoulay E, Fieux F, Moreau D, Thiery G, Rousselot P, Parrot A, Le Gall J-R, Dombret H, Schlemmer B (2003) Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 167:1329–1333PubMed Azoulay E, Fieux F, Moreau D, Thiery G, Rousselot P, Parrot A, Le Gall J-R, Dombret H, Schlemmer B (2003) Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 167:1329–1333PubMed
3.
Zurück zum Zitat Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le Gall JR, Fermand JP, Schlemmer B (1999) Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 25:1395–1401PubMed Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le Gall JR, Fermand JP, Schlemmer B (1999) Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 25:1395–1401PubMed
4.
Zurück zum Zitat Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complications. Crit Care Med 31:104–112CrossRefPubMed Benoit DD, Vandewoude KH, Decruyenaere JM, Hoste EA, Colardyn FA (2003) Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complications. Crit Care Med 31:104–112CrossRefPubMed
5.
Zurück zum Zitat Blot F, Guiguet M, Nitenberg G, Leclercq B, Gachot B, Escudier B (1997) Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 33:1031–1037CrossRefPubMed Blot F, Guiguet M, Nitenberg G, Leclercq B, Gachot B, Escudier B (1997) Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 33:1031–1037CrossRefPubMed
6.
Zurück zum Zitat Brunet F, Lanore JJ, Dhainaut JF, Drefus F, Vaxelaire J, Nouira S, Giraud T, Armaganidis A, Monsallier JF (1990): Is intensive care justified for patients with hematological malignancies? Intensive Care Med 16:291–297PubMed Brunet F, Lanore JJ, Dhainaut JF, Drefus F, Vaxelaire J, Nouira S, Giraud T, Armaganidis A, Monsallier JF (1990): Is intensive care justified for patients with hematological malignancies? Intensive Care Med 16:291–297PubMed
7.
Zurück zum Zitat Conti G, Marino P, Cogliati A, Dell’Utri D, Lappa A, Rosa G, Gasparetto A (1998) Noninvasive ventilation for the treatment of acute respiratory failure in patients with hematologic malignancies: a pilot study. Intensive Care Med 24:1283–1288PubMed Conti G, Marino P, Cogliati A, Dell’Utri D, Lappa A, Rosa G, Gasparetto A (1998) Noninvasive ventilation for the treatment of acute respiratory failure in patients with hematologic malignancies: a pilot study. Intensive Care Med 24:1283–1288PubMed
8.
Zurück zum Zitat Epner DE, White P, Krasnoff M, Khanduja S, Kimball KT, Knaus WA (1996) Outcome of mechanical ventilation for adults with hematologic malignancy J Investig Med 44:254–260 Epner DE, White P, Krasnoff M, Khanduja S, Kimball KT, Knaus WA (1996) Outcome of mechanical ventilation for adults with hematologic malignancy J Investig Med 44:254–260
9.
Zurück zum Zitat Estopa R, Torres Marti A, Kastanos N, Rives A, Agusti-Vidal A, Rozman C (1984) Acute respiratory failure in severe hematologic disorders. Crit Care Med 12:26–28PubMed Estopa R, Torres Marti A, Kastanos N, Rives A, Agusti-Vidal A, Rozman C (1984) Acute respiratory failure in severe hematologic disorders. Crit Care Med 12:26–28PubMed
10.
Zurück zum Zitat Evison JM, Rickenbacher P, Ritz R, Gratwohl A, Haberthűr Ch, Elsasser S, Passweg JR (2001) Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly 131:681–686PubMed Evison JM, Rickenbacher P, Ritz R, Gratwohl A, Haberthűr Ch, Elsasser S, Passweg JR (2001) Intensive care unit admission in patients with haematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly 131:681–686PubMed
11.
Zurück zum Zitat Ewig S, Torres A, Riquelme R, El-Ebiary M, Rovira M, Carreras E, Rano A, Xaubet A (1998) Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J 12:116–122CrossRefPubMed Ewig S, Torres A, Riquelme R, El-Ebiary M, Rovira M, Carreras E, Rano A, Xaubet A (1998) Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J 12:116–122CrossRefPubMed
12.
Zurück zum Zitat Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, Champlin RE (2000) Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 28:1014–1017PubMed Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H, Champlin RE (2000) Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 28:1014–1017PubMed
13.
Zurück zum Zitat Johnson MH, Gordon PW, Fitzgerald FT (1986) Stratification of prognosis in granulocytopenic patients with hematologic malignancies using the APACHE-II severity of illness score. Crit Care Med 14:693–697PubMed Johnson MH, Gordon PW, Fitzgerald FT (1986) Stratification of prognosis in granulocytopenic patients with hematologic malignancies using the APACHE-II severity of illness score. Crit Care Med 14:693–697PubMed
14.
Zurück zum Zitat Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Apache II: a severity of disease classification system. Crit Care Med 13:818–829PubMed Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Apache II: a severity of disease classification system. Crit Care Med 13:818–829PubMed
15.
Zurück zum Zitat Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Prognosis in acute organ-system failure. Ann Surg 11:685–693 Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) Prognosis in acute organ-system failure. Ann Surg 11:685–693
16.
Zurück zum Zitat Kongsgaard UE, Meidell NK (1999) Mechanical ventilation in critically ill cancer patients: outcome and utilisation of resources. Support Care Cancer 7:95–99PubMed Kongsgaard UE, Meidell NK (1999) Mechanical ventilation in critically ill cancer patients: outcome and utilisation of resources. Support Care Cancer 7:95–99PubMed
17.
Zurück zum Zitat Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB (1999) Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med. 160: 1957–1961 Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB (1999) Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med. 160: 1957–1961
18.
Zurück zum Zitat Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G, Ehninger G, Schuler U (2002) Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 28:1294–1300CrossRefPubMed Kroschinsky F, Weise M, Illmer T, Haenel M, Bornhaeuser M, Hoeffken G, Ehninger G, Schuler U (2002) Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies. Intensive Care Med 28:1294–1300CrossRefPubMed
19.
Zurück zum Zitat Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicentre study. JAMA 270:2957–2963PubMed Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicentre study. JAMA 270:2957–2963PubMed
20.
Zurück zum Zitat Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ (1986) Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med. 12:317–324 Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ (1986) Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med. 12:317–324
21.
Zurück zum Zitat Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ (1988) Prognosis of patients receiving intensive care for life threatening medical complications of haematological malignancy. Br Med J 296:1025–1029 Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ (1988) Prognosis of patients receiving intensive care for life threatening medical complications of haematological malignancy. Br Med J 296:1025–1029
22.
Zurück zum Zitat Massion PB, Dive AM, Doyen C, Bulpa P, Bosly A, Installe E (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30:2260–2270CrossRefPubMed Massion PB, Dive AM, Doyen C, Bulpa P, Bosly A, Installe E (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30:2260–2270CrossRefPubMed
23.
Zurück zum Zitat Meert AP, Close L, Hardy M, Berghmans T, Markiewicz E, Sculier JP (2003) Noninvasive ventilation: application to the cancer patient admitted in the intensive care unit. Support Care Cancer 11:56–59PubMed Meert AP, Close L, Hardy M, Berghmans T, Markiewicz E, Sculier JP (2003) Noninvasive ventilation: application to the cancer patient admitted in the intensive care unit. Support Care Cancer 11:56–59PubMed
24.
Zurück zum Zitat Peters S, Meadows JA, Gracey D (1988) Outcome of respiratory failure in hematologic malignancy. Chest 94:99–102PubMed Peters S, Meadows JA, Gracey D (1988) Outcome of respiratory failure in hematologic malignancy. Chest 94:99–102PubMed
25.
Zurück zum Zitat Poletti V, Trisolini R, Tura S (2002) Pulmonary disease in patients with hematologic malignancies. Sarcoidosis Vasc Diffuse Lung Dis 191:29–45 Poletti V, Trisolini R, Tura S (2002) Pulmonary disease in patients with hematologic malignancies. Sarcoidosis Vasc Diffuse Lung Dis 191:29–45
26.
Zurück zum Zitat Rabe C, Mey U, Paashaus M, Musch A, Tasci S, Glasmacher A, Schmidt-Wolf IG, Sauerbruch T, Dumoulin FL (2004) Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis. J Crit Care 19:29–35PubMed Rabe C, Mey U, Paashaus M, Musch A, Tasci S, Glasmacher A, Schmidt-Wolf IG, Sauerbruch T, Dumoulin FL (2004) Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis. J Crit Care 19:29–35PubMed
27.
Zurück zum Zitat Schuster D, Marion J (1983) Precedents for meaningful recovery during treatment in a medical intensive care unit: outcome in patients with hematologic malignancy. Am J Med 75:402–308CrossRefPubMed Schuster D, Marion J (1983) Precedents for meaningful recovery during treatment in a medical intensive care unit: outcome in patients with hematologic malignancy. Am J Med 75:402–308CrossRefPubMed
28.
Zurück zum Zitat Shorr AF, Moores LK, Edenfield WJ, Christie RJ, Fitzpatrick TM (1999) Mechanical ventilation in hematopoietic stem cell transplantation. Chest 116:1012–1018PubMed Shorr AF, Moores LK, Edenfield WJ, Christie RJ, Fitzpatrick TM (1999) Mechanical ventilation in hematopoietic stem cell transplantation. Chest 116:1012–1018PubMed
29.
Zurück zum Zitat Silfvast T, Pettilä V, Ihalainen A, Elonen E (2003) Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand 47:301–306PubMed Silfvast T, Pettilä V, Ihalainen A, Elonen E (2003) Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand 47:301–306PubMed
30.
Zurück zum Zitat Trebmlay LN, Hyland RH, Schouten BD, Hanly PJ (1995) Survival of acute myelogenous leukemia patients requiring intubation/ventilatory support. Clin Invest Med 18:19–24PubMed Trebmlay LN, Hyland RH, Schouten BD, Hanly PJ (1995) Survival of acute myelogenous leukemia patients requiring intubation/ventilatory support. Clin Invest Med 18:19–24PubMed
31.
Zurück zum Zitat Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707–710CrossRefPubMed
32.
Zurück zum Zitat Wedding U, Bokemeyer C, Meran JG (2004) Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG). Onkologie 27:72–82PubMed Wedding U, Bokemeyer C, Meran JG (2004) Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG). Onkologie 27:72–82PubMed
Metadaten
Titel
Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit
verfasst von
Radoslaw Owczuk
Magdalena A. Wujtewicz
Wioletta Sawicka
Anna Wadrzyk
Maria Wujtewicz
Publikationsdatum
01.05.2005
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2005
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-004-0750-y

Weitere Artikel der Ausgabe 5/2005

Supportive Care in Cancer 5/2005 Zur Ausgabe

Forthcoming Meetings

Forthcoming Meetings 13/5

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.